Agoracom Blog Home

Author Archive

Else Nutrition $BABY.ca $BABYF to Present at the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 7:26 AM on Monday, November 2nd, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Announced that it will be participating at this year’s NASPGHAN (North American Society for Pediatric Gastroenterology, Hepatology and Nutrition), November 1 st to 7 th
  • Else’s virtual booth will enable live conversations with small groups, and one-on-one educational sessions, among the nearly 2,600 anticipated attendees
  • The forum will place Else Nutrition alongside some of the leading blue-chip nutrition companies, including Pfizer, Abbott Laboratories, Nestle and Danone

VANCOUVER, BC , Nov. 2, 2020  – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (” Else ” or the ” Company “), a developer of plant-based alternatives to dairy-based baby nutrition, is pleased to announce that it will be participating at this year’s NASPGHAN (North American Society for Pediatric Gastroenterology, Hepatology and Nutrition), November 1 st to 7 th .  Else’s virtual booth will enable live conversations with small groups, and one-on-one educational sessions, among the nearly 2,600 anticipated attendees. The forum will place Else Nutrition alongside some of the leading blue-chip nutrition companies, including Pfizer, Abbott Laboratories, Nestle and Danone.

“We are working diligently to build awareness of our products with America’s top pediatricians and medical experts” said Mrs. Hamutal Yitzhak , CEO and Co-Founder of Else. “We want them to form their own unbiased opinion of ELSE’s health benefits for babies and we are excited to introduce and promote our plant-based product to this professional crowd at NASPGHAN .  Educating the medical community is a major pillar of our marketing strategy,” she added.

This year’s annual summit is virtual due to COVID-19.

Else Nutrition’s Plant-Based Complete Nutrition for Toddlers & Babies (12+ mo.) is now available for sale on Else’s e-store at elsenutrition.com , and on Amazon.com.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean, plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition organizations. Many of Else advisory board  members held executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in prominent roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents.  Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate.  Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Empower Clinics $CBDT.ca Growth Strategy Accelerates With Recent Major Initiatives. Updates Status And Outlook Into 2021 $WELL.ca $DOC.ca $DOCRF $VMD.ca $VPT.ca $ADK.ca

Posted by AGORACOM-JC at 7:23 AM on Monday, November 2nd, 2020

2020 Revenue Growth The Company has experienced significant revenue growth over the past year as evidenced by the following results:

  • 2019 + 86% To $2.03M
  • Q4 + 217% To $625,000
  • Q1 + 416% To $790,000
  • Q2 + 56% To $923,000

This performance has translated into the following year-to-date in 2020:

  • Revenue $1.7M vs $745K = 130% Growth
  • Patient Visits 12,400 vs 5,500 = 125% Growth

VANCOUVER BC / November 2, 2020 / EMPOWER CLINICS INC. Empower Clinics (CBDT:CSE)(EPWCF:OTC)(8EC:FRA) (the “Company” or “Empower“), an integrated healthcare company serving a database of 165,000 patients through clinics in the southwest United States, a telemedicine platform and medical diagnostics laboratory, is pleased to provide shareholders with a status report on many initiatives announced over the past several weeks for the purposes of providing greater visibility into the Company’s outlook into 2021.

Steven McAuley, CEO of Empower Clinics stated “2020 is the year that established Empower Clinics as a formidable Health & Wellness Company with a solid foundation and great growth prospects. Given the speed at which we have been moving since I took over the leadership reigns in 2019, it is prudent to take a moment to provide our shareholders with both a current snapshot, as well as, our expectations for continued growth into 2021.”

HIGHLIGHTS & UPDATES

  • 2020 Revenue Growth The Company has experienced significant revenue growth over the past year as evidenced by the following results:
    • 2019 + 86% To $2.03M
    • Q4 + 217% To $625,000
    • Q1 + 416% To $790,000
    • Q2 + 56% To $923,000

This performance has translated into the following year-to-date in 2020:

  • Revenue $1.7M vs $745K = 130% Growth
  • Patient Visits 12,400 vs 5,500 = 125% Growth

Going forward, given the Company’s diversification into telemedicine, COVID-19 testing, medical laboratory testing for enterprise customers, and the proposed clinic expansion into Canada, all of which serves to diversify Empower well beyond our Southwestern U.S. clinic operations, going forward “patient visits” will be just one of many of the Company’s overall KPI’s (Key Performance Indicators).

  • Kai Medical Laboratory COVID-19 Testing Growth Includes Film & Television Industry Empower completed the closing of the Kai Medical Laboratory acquisition with the signing of the Member Purchase Interest Agreement October 5, 2020 and then subsequently completed the filing of all required regulatory documents with the State of Texas and other regulatory bodies.

The Company is now working through integration and implementing aggressive growth strategies including servicing new COVID-19 testing contracts for the film & television industry and supporting the Sun Valley Health COVID-19 RT-PCR and rapid antibody testing programs in the state of Arizona.

  • Sun Valley Health COVID-19 Regional Testing Growth Sun Valley Health with the support of Kai Medical Laboratory testing and medical billing capabilities, is expanding its RT-PCR testing with the commencement of drive-up testing for consumers in Mesa, Arizona and within clinic locations. The program allows the Company to provide free COVID-19 testing for consumers with Medicare and Medicaid insurance coverage in Arizona and for consumers who do not have active health insurance coverage in the state.
  • $1,100,000 Proposed Private Placement The previously announced proposed private placement with Mackie Research Capital Corporation as sole agent and sole bookrunner (the “Agent”) on October 21, 2020 remains on track for closing as planned on or about the week of November 2, 2020.
  • Canadian Clinic Acquisition The recently announced non-binding term sheet for the acquisition of Lawrence Park Health and Wellness Clinic Inc., 1100900 Canada Inc. dba Atkinson, and Momentum Health Inc. collectively (“Momentum Health”) is progressing as planned through the final due diligence phase with an anticipated closing in November 2020.
  • Q3 2020 Financial Statements The Company anticipates filing its third quarter 2020 financial statements and MD&A well in advance of the November 30, 2020 filing deadline. Financial and accounting controls supported by CFO Kyle Appleby enable the Company to maintain high compliance standards.

McAuley went on to say “Our company is rapidly evolving into providing an integrated healthcare experience that spans from testing to treatment by combining cutting edge technologies including telemedicine and state of the art lab testing. Add to this the fact that we are now serving enterprise level clients as promised and partnering on initiatives such as our recently announced travel bubble, it’s safe to say we are on the path to becoming a formidable small cap health & wellness company in 2021. I want to thank our loyal shareholders for trusting my leadership transition, welcome all of our newest shareholders and we look forward to delivering continued accelerated growth in 2021 and well beyond.”

ABOUT EMPOWER:

Empower is creating a network of physicians and practitioners who integrate to serve patient needs, in-clinic, through telemedicine, and with an expanded suite of physician-based services. A simplified, streamlined care model bringing key attributes of the healthcare supply chain together, always focused on patient experience. The Company provides COVID-19 testing services to consumers and businesses as part of a four-phased nationwide testing initiative in the United States. Empower recently acquired Kai Medical Laboratory, LLC as a wholly owned subsidiary with large-scale testing capability and will lead our diagnostic and scientific advancement.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley

Chief Executive Officer

CONTACTS:

Investors:
Dustin Klein
Director
[email protected]
720-352-1398

Investors:
Steven McAuley
CEO
[email protected]
604-789-2146

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the expected benefits to the Company and its shareholders as a result of the acquisition of Kai Medical Laboratory; the anticipated date of closing of the Momentum Health acquisition and the occurrence thereof; the expected number of clinics and patients following the proposed closing; the future potential success of Kai Medical Laboratory; the future success of the Sun Valley’s franchise model; the completion of the private placement, date of closing or the occurrence of a closing; the impact if any of COVID-19 testing by Sun Valley Health and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2020 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Momentum Health acquisition may not be completed on the terms expected or at all; that the Company’s products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

VIDEO – Primo Discusses MOU For Exclusive Rights to Sell Rapid COVID-19 Test Kits In Canada + Upcoming Spinout of Marianna Naturals

Posted by AGORACOM-JC at 5:52 PM on Friday, October 30th, 2020

Welcome to be on the press release a production of AGORACOM in which we speak to small cap management about their company with us today happy to have him back Richard Cedric is managing director at Primo Nutraceuticals trades on the CSE under the stock symbol P. R. M. O. and 4 friends the US under B. U. G. V. F. now for those who knew the story there’s been a lot going on a lot of re position going on at the company our basic couple these are helping their their their funding the rapid growth of production process retail and branding of cannabis and non cannabis natural health products being important for this off for this purpose that they’ve invested several brands they’re pursued partnerships with retailer distribution companies in Canada the U. S. they got a spin out that’s common they’ve got there M. D.E. L. that’s our medical device License and that’s important because the press release the may possibly talk about today is a Primo signs and amble you for the exclusive rights to sell the rapid Covid 19 test kits in Canada. These are the colloidal gold method Richard welcome back man. Hey thanks for having me great intro right up. Well look Hey that look above the first thing people said people think about when they see something like this is saying all now somebody else trying to get to the Covid19 space but this rapid test it is currently registered with the with the FDA and it’s got its C. E. declaration with with the European community as it are and as has already been operating in China so before we get the details of the deal what is it what do these mean exactly and why is that important to stopping the credibility of you guys bring in have the exclusive rights to this test well the first thing that that we did that brings credibility to us is establishing and getting our medical devices license and our procurement number from health Canada so we could go ahead and and actually import and and submit products like this to help Canada for approval so that’s the first step I mean a lot of companies like Hey I I got this test yet we’re going to be selling it you’re the U. S. with the F. B. through the FDA approval and so forth we’re not we’re not even talking about that we have to be approved first by getting a medical devices license you for health Canada will even look at us so that medical devices license allows us to import and shipped out gloves and N95 masks gloves and testing kits and  it’s only I can go sign up for this.  Articulate behind license first and what allowed us to get the medical devices license is because we had our natural health product number from health Canada which was issued before the medical devices license so there was a trail here leading up to this and it had everything to do with capitalizing on the medical devices license industry given this you know sadly to say this pandemic that is is happening but this is our way of trying to help out in and bring these testing kits to fruition so this particular testing kit was used in during the largest outbreak in China back in February so this test kit has been used by the CDC. It was basically donated to hospitals the CDC distributed in the mostly severe we infected areas and it already comes with clinical trials so the. Health Canada is gonna be requesting any company that is submitting a test kit to have clinical trials and there’s probably about 10 to 15 maybe 20 of them who have submitted a similar test kit or a test kit but not like this because these clinical trials have already been completed almost a year ago where other companies submit application are in the midst of clinical trials so we feel that we’re we’re gonna be out pushed to the top of the line only because clinical trials of already been completed S. all I can is the Guinea pig because it’s sold in other countries already right now once you name those often let’s talk about what that means yeah at present Iran Italy and the United States and other red zone our countries are already using it and obviously coming out of China who seem to be the leader in providing a direction on how to how to combat this cold it will be 19 pandemic is is relevant other companies are actually in the U. S. you know I’ve come up with the product they develop it in the U. S. and now they’re in clinical trial phase right so again we’re idea there behind you technically because this product already has a clinical trials ready to go that’s right that’s right clinical trials of. So part of this is you need to get product license approved by health Canada at that point you’ll have official dealer distribution distributor status with with your Chinese partner you got that M. D. L. we know that so that put you like you said probably near the top do you have an ETA for how long it might take to get this approved by health Canada and and W. W. get even what’s the probability is 5050 is a very high degree of probability what do you guys seeing as investors in the world don’t know you know if these things are getting approved and or what right. Okay so from what we’ve been made aware of is that there’s been one test kit approved so far in Canada and the reason why we and we should be hearing back anywhere from 15 to 25 days as to if we’ve been approved and the reason why we feel that we would be ahead of the line is given our clinical trials right and with that we were do you attain those objectives of of having clinical trials it was a win would you guys submit when you guys submit to health Canada last week it was a couple days after we announce the PR all right so you talk about last. Right. Well it’s October 23 so you talk and let’s say your worst case there are 25 days talk about November 20 give or take time yeah in worst case yeah and mid November we should know if we have or haven’t gotten it I really don’t see why we wouldn’t get it if we are past clinical trial phase but you never know and it’s a high I would say maybe 90-99 percent believe that we might get it because that’s what I’m being told what’s slowing down these companies is that they don’t have their clinical trials completed right right and you guys have got a dispute in the field the target it reduce the rand in Italy in the US over pretty big hot zone so I gotta figure you know health Canada have a problem if they’re already being used there Richard let’s assume you guys got it okay first second half the battle is getting a license like this are you know getting approval getting a partnership  you guys are are teaming up with this you are with with the company is great Neo-Nostics. You get it it’s already go how the other half the battle is how do you make money from it so what I mean by that is if you can answer what’s the marketing plan how do you get this out there with the price points you know what the numbers look like what because you guys I’m sure before you came down this path I’ve probably run some numbers maybe you can give us an idea of where you guys looking at. Okay so numbers wise we have out like like I said we’d be the same the. Product license and distribute their official dealer in Canada there’s 500000 units put aside for us the numbers are pretty big if we’re talking about $50 or 25 to $50 per her up unit you know we’re we’re in the $25000000 range right so around there and I mean the margins are yet to be discovered but gross income that we’d be sharing with Neo-Nostics is north the $20000000 range or all of them all right. Are you trying to be more B. 2 B. are you going to have this you’re going to go up. No that’s. Both. I think right away what we’ll do is contact the distributors that are already you know in that in that framework as well as bring on people to do the B2 B. I mean we’ve got we’ve got actually an ad on indeed for these these types of positions to be filled and we’re doing a financing at $0.10 for $5M to basically be able to follow through with getting these products overboard over over to our shores and then distributed effectively so we’ll be doing a combination of both will let the distributors know that we’ve got this product for sale as well as lead but the large institutions like airports schools and government German agents know that we’ve got this test kit available and approved by health Canada. The research have you start to reach out to them just to kind of you know just in case yeah I I actually in the approval process there was a a section there that basically would let all the German agents know that we’ve been about this particular product has been approved by health Canada all right all right so you know yet what’s the feedback and kind of seeing I’m curious you know are people saying Hey guys once you get this will will definitely want to be taken orders or would use would you stand out we’re we’re talking specifically to schools as well as hospitals and we’re basically getting quoted up 50 thought looking for quotes are 50000 products at a time that’s so far been our largest request for proposal was 50000 units so 10 percent of what are what are actual inventory would be so I think this thing is going to fly off the shelves like one mining company alone which would be interested in a 50000 units because these units are disposable right it’s similar to a pregnancy test your your right **** on the finger draws a little bit of blood and within a couple of minutes you’re you’re aware of what what do you have it or not and there’s a video on the link to the press release of your data shows you how the product works and that’s available for everybody to see it all yeah it was the second to last press release. . But that probably start it went in to add George’s that further back anticipating this we hired a gentleman by the name of Dan Duquette who’s an ex MLB executive and entered the PPE space are a little bit sooner than we did but given his contacts with like you know individuals that are in government positions you know he’s going to be he’s an example of the kind of people that were looking to join the team to help get rid of this casket worker remote the Tuscan. All right so let’s sit back on that that’s a great overview and let’s wait for mid November to see where hopefully you get that first as a Canadian I hope you get that because a citizen would be great to know look I’ve got family I’ve got friends and yelled in in Ontario their backlog 2 or 3 weeks almost doesn’t matter if you get if you get a result now if it’s if you find out you’re positive the but the tells of 2 weeks ago you price front the 0people anyways so right to have it be great to know that these these will be available yeah so and then secondly as a shareholder absolutely right B. you know because so let’s wait till mid November I have our fingers crossed that that happens for both citizens and for shareholders all the other peace news I want to talk about is a pure primo shareholder today or rethinking become approval shareholder you’re going to get our share in Marianna you know what we talk about that and tell us where it’s at yeah for sure so back on April 29 we signed a definitive agreement to help assist beauty kitchen really is the company going to be course public but eventually representing a beauty kitchen so yeah you know we started out on April 29 and at the same time Joel who’s one of our directors was the is the CEO of Marianna he’s been working diligently and so free up pushing this through so it was issued we put out a press release actually yesterday that it retained a transfer agent and has secured its number so that shows that we are very close to this thing trading I think it’ll be trading mid to end of January but you know there’s no reason to wait so yeah basically the ratio would be for every share that you own in primo you’ll get a free share of Mariana and that’s not and that’s saying something because people got a pretty tight share structure right. Yeah we’ve only got that right now we’ve got 10.5m shares outstanding up until January where we will have a total of about 23 to call the 24000000 shares out by mid January so yeah and the mean time you know if we do get this this approval and with only 20M shares outstanding and 6M in the float I see companies with those types of ratios get into the tent you know multiple up 5 to 10 points right so this is at no time to wait on when you’re thinking about getting into the stock that’s only got 10000000 shares in this trading at $0.12 yeah that that yeah that’s fantastic and tells a little bit about the about the business that’s going to be underlying you know the Marianna. We got the bill the underlying business of Marianna to get his beauty kitchen so beauty kitchen is a business that has been around since 2014 she was basically became popular by well I live streaming videos where she was taking products that you find in your  kitchen cabinet and make up you know any type of cosmetics lipsticks and so forth beauty products in general and it took off so she’s developed a line of a product’s Marianna core and beauty kitchen and Marianna’s objective is to add the CBD component to our beauty kitchen’s product line but you know that doesn’t stop the company from possibly doing a a a you know a small takeover of beauty kitchen’s existing revenue shares so that’s something to look at so it’s really you know when you talk about Marianna natural court it’s the subsidiary of beauty kitchen and beauty kitchen is all over the internet for products and so forth so we’ll be all. This is that’s brought into the public company hello hi or the network AV I know I believe about it over a period of time Marianna could possibly become beauty kitchen or vice versa beauty kitchen will end up being the buckle of with depending on how much what percentage is required but similar to what we did with the with thrive wellness 39 percent you know interest is probably something that Marianna might as well might do as well in beauty kitchen. Yeah at some point be great what we do is maybe after November 15 is you know just to corporate data relays out each 1 of these because you guys are you know you kind of funding these companies are investing in summer brand partnerships would be greater because you know the the after after primo went through some good restructuring it’s really starting to set itself up for a winning it all winning structure for 2021 would be great if we agree with that I mean that was the reason for the name change so we can capitalize on not only the THC and CBD market but the natural health market and it just opens up a wide variety of options that we have and even prior to. This acquisition of the up or M. O. U. we announced a cut to press releases to do with the mushroom market you’ll see that David no shot is an individual that has was granted the ability to do research on Gino typing it Kimmel typing of CBD products so now he’s going to come on board with us and do the same type of of research for the mushroom space and hopefully you know we could be one of the companies that gets the second micro dosing license so because we’re a nutraceutical company it’s allowed us to do that and our short term objective. Is is the seat is the PP space and our long term objective is you know sticking to the natural nutraceutical space and you know developing the this I. P. through the psilocybin with David no shot as well as you know with a lot of these marijuana companies you can get get into a project on pennies on the dollar but he’s on the dollar and we’re looking at farms right now which can encompass art sheet C. B. D. and continue on with the P. P. as a nutraceutical company right well great that you got an issue for both the short term like this M. O. U. for the rights of the covert 19 rapid test EDM term yeah like Marianna and and the long term through what you’re doing with the R&D. and the silence of bins and and and the psychedelic side I think that’s a great combination for a small cap company well you know what another thing is to it was pretty critical changing the name to primo and becoming a nutraceutical company because we’re getting contact from trivago’s in the US wanted to piggy back in doing similar what we are doing with Marianna so once we get Marianna through the goal line we’re gonna be doing a lot more spin outs because we was successfully done one and we know what to do because you and I both know lot of companies announced they’re doing a spin out and a lot of them don’t even come through so we want to get this one through the finish line show that we’re a company that actually does what they say that they’re going to do and and and continue on with identifying you know nutraceutical brands that can fall under the cream on on Broadway and primo is a terrific branding name when you consider media. Yes because what do you ask what for when you’re looking for a a a quality product you ask if it’s primo give me the primo stuff baby primo stuff baby now it’s great to know I looked at how to get to know that you got that one as a shareholder that I am sure older people are watching that you’re going to get a one for a one for one spin out that’s just almost too good to give half right we don’t and and and again we just announced that they’ve secured the transfer agent because they received . Nothing says that we are anticipating trading our common shares swiftly in the future than that so yeah right yeah absolutely I mean still has to happen look for the covert 19 does still got to get the health Canada for the spin out that’s going to happen but the fact that they’re both on track and they’re both locked up. On the menu you’re not just taking shots in the dark here which is great I’ll I’ll be honest with you Marriott Corp would be trading by now. But we’ve been you know the rollback caught you know because the delay and all we’re waiting on is basically calling our AGM which is we’re weeks away from that once that happens you know we’re we’re basically at the goal line with the spin out. Set number great 2021 man. 2021 great see the you guys came through some turbulence earlier in the year and now you know you’re really getting the ship on the right direction and can’t wait to have you back Richard. Yeah thanks George appreciate your guys support and again remember we’re out we’re doing a financing here $0.10 so if any of your people are interested I’m sure they can contact us on the website or Regis any by email got a great story I’m assuming you’re in the private placement also means that you’re going to get you know that and that share in Marianna right off get looks like you’re actually securing your your share Marianna because because yeah you’re you’re participating in the P. P. but that is a guaranteed if you did you participate in the PP you secure your position America.  You can watch and or if you listen by podcast to Richard Cindric managing director primo nutraceuticals trade on the CSE under the stock symbol P. R. M.O a fantastic name it’s the Primo name and look if you want more information to get kind of caught up with the story because you’re probably discovery again the company had to go through some restructuring but did a great job of pivoting you know seeing it more problems in the market pivoting out and and really doing some great things now as you heard from Richard self get to court get too bored calm start your research thank god over the primo site do more research there hope you discovered your next great small cap companies thanks for joining us everyone have a fantastic day see you next time.

Else Nutrition $BABY.ca $BABYF Plant-Based Infant Foods Launch in Over 380 US Retail Locations $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 4:09 PM on Friday, October 30th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Else Nutrition Holdings which develops plant-based alternatives to dairy milk-based baby foods, announces the early availability of its innovative products in US retail stores. The company expects to begin first retail sales through KeHE distributors in the western and southern regions of the United States as early as the end of November 2020.

Else began trading on the Toronto exchange last June and saw huge stock market interest upon its launch, being touted as hot stock to watch, in its plans to disrupt dairy nutrition for infants. Else says thats its products are the first viable choice other than dairy and soy in in this category for over 120 years.

Up to four regional customers and one national key account, for a total of 380 shops, will be served before the start of the Christmas season, following the recent successful launch of its plant-based baby food products through its online store and via Amazon. Else is now working diligently through a network of food brokers and KeHE sales partners to acquire strategic customers in the stationary trade in various key regions of the USA.

“The lively interest in our product makes us very optimistic. Parents and families have long been waiting for a plant-based alternative to milk-based baby food. Soon, parents across the United States will be able to buy our product in a shop near them and also order it through online retailing,” said Hamutal Yitzhak, CEO and founding member of Else.

Source: https://vegconomist.com/companies-and-portraits/else-nutrition-plant-based-infant-nutrition-launches-in-over-380-us-retail-locations/

$VALE completes first sale of iron ore using #blockchain technology with Nanjing Iron & Steel – SPONSOR: Blockchain Foundry $BCFN.ca $HUT.ca $BITF.ca $GLXY.ca $HIVE.ca $VYGR.ca

Posted by AGORACOM-JC at 3:33 PM on Friday, October 30th, 2020

SPONSOR POST:

http://blog.agoracom.com/wp-content/uploads/2020/10/blockchain-foundry-square.png

BCFN:CSE

  • A leading North American blockchain development firm
  • 2020 H1 Revenue Of ~$900,000
    • 187% Year Over Year Growth
    • Positive Net Income
  • Self sustaining consulting practice with growing pipeline and potential upside from product development and commercialization
  • Partnered with Binance, the largest digital asset trading platform in the world, to leverage the Syscoin platform.
  • A Blockchain company with Real Products, Real Customers, Real Revenues and Real Income
  • Blockchain Foundry is a “Blockchain 2.0” company that has survived and will thrive  

Hub On AGORACOM / Corporate Profile

Vale completes first sale of iron ore using blockchain technology with Nanjing Iron & Steel

  • Vale, one of the world’s largest mining companies, completed its first sale of iron ore using blockchain technology with Nanjing Iron & Steel Group International Trade Co., Ltd., a subsidiary of Nanjing Iron and Steel Co., Ltd. (NISCO) for a cargo of 176,000 tons of Brazilian Blend Fines (BRBF) from Teluk Rubiah Maritime Terminal, in Malaysia, to China.
  • Vale said this transaction is aligned with its strategy of becoming a more innovative and customer-centered company through greater integration with clients and partnering for the development of new solutions.

Vale also called it an important milestone towards the digitalization of the sales and trade process, bringing innovation to the traditional paper-intensive trade transactions and offering a better service to the clients as well as predictability in the steel value chain.

The Letter of Credit (LC) was issued through the Contour blockchain platform while the shipping documents and the electronic Bill of Lading were handled via essDOCS’ CargoDocs solution—with all actions carried out through a single, interfaced platform consolidated in Contour. The transaction also had the support from DBS Bank Ltd and Standard Chartered Bank Malaysia Berhad.

The integrated transaction enabled end-to-end security and transparency with real time visibility of the documentation to all stakeholders, drastically reducing the amount of emails and paperwork exchanged among the parties and providing enhanced user experience through access to a single solution to execute the trade.

Source: https://www.greencarcongress.com/2020/10/20201030-valeblockchain.html

Iconic $ICM.ca Receives Core Drilling Geochemistry for Bonnie Claire #Lithium Project, Nevada $NRM.ca $CYP.ca $LI.ca $ALB $LAC.ca

Posted by AGORACOM-JC at 3:08 PM on Friday, October 30th, 2020
  • Received geochemical results for sediments from two core holes at the Bonnie Claire Lithium Deposit in Nevada
  • Both drill holes contain intercepts of +1,000 ppm lithium and continue to show that results are consistent with those from prior drilling
  • Core hole BC2001C intersected 67 meters (220 feet) averaging 1209 ppm Li and contained a high of 1710 ppm Li. Core hole BC2002C contained a high of 1070 ppm Li

Vancouver, British Columbia–(October 30, 2020) – Iconic Minerals Ltd. (TSXV: ICM) (OTC Pink: BVTEF) (FSE: YQGB) (“Company” or “Iconic”) is pleased to announce that it has received geochemical results for sediments from two core holes at the Bonnie Claire Lithium Deposit in Nevada. Both drill holes contain intercepts of +1,000 ppm lithium and continue to show that results are consistent with those from prior drilling. Sediment geochemical analysis was done by ALS Chemex of Reno, Nevada.

Core hole BC2001C intersected 67 meters (220 feet) averaging 1209 ppm Li and contained a high of 1710 ppm Li. Core hole BC2002C contained a high of 1070 ppm Li. Occasional lighter colored sediments seen in the core may indicate some leaching of soluble elements is occurring. Water samples, highly diluted by added drill water, were taken from each core hole. The water samples were analyzed for dissolved lithium by Western Environmental Testing of Sparks, Nevada. Of the four samples taken the high for dissolved lithium was 38 ppm. The highest water sample taken in all of Iconic’s previous drilling at Bonnie Claire, with the exception of one non-repeatable sample, was 4.1 ppm Li. As a result of these encouraging results the water sampling was also taken in the RC drilling program. These samples were taken at rod changes after clearing the hole of drill water.

The RC (reverse circulation) drilling has now been completed. A total of four holes ranging from 61 to 109 meters (200 to 358 feet) were drilled to expand the resource and collect samples for metallurgy. Samples have been sent for testing to ALS Chemex of Reno Nevada for assaying. The drilling extended the current resource approximately 2,500 meters (8,200 feet) to the south.

The Bonnie Claire Lithium Property Characteristics:

The Property is located within Sarcobatus Valley that is approximately 30 km (19 miles) long and 20 km (12 miles) wide. Quartz-rich volcanic tuffs, that contain anomalous amounts of lithium, occur within and adjacent to the valley. Geochemical analysis of the local salt flats has yielded lithium values up to 340 ppm. The gravity low within the valley is 20 km (12 miles) long, and the current estimates of depth to basement rocks range from 600 to 1,200 meters (2,000 to 4,000 feet). The current claim block covers an area of 35 km2 (13.5 mi2) with potential to be underlain by lithium-rich sediments.

Richard Kern, Certified Professional Geologist (#11494) and CEO of Iconic is the Qualified Person who has prepared and reviewed this press release in accordance with NI 43-101 reporting standards.

On behalf of the Board of Directors

SIGNED: “Richard Kern
Richard Kern,
President and CEO

Contact:
Keturah Nathe
VP Corporate Development
(604) 336-8614

For further information on ICM, please visit our website at www.iconicminerals.com.

The Company’s public documents may be accessed at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Early Response To #Amazon $AMZN Web Services And Loop Insights $MTRX.ca $RACMF Showcase Of Loop Venue Tracing Solution To Global Audience Indicates Great Success; Loop Obtains DTC Eligibility for Its Common Shares $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 7:13 AM on Friday, October 30th, 2020
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png
  • Announced that early response from its interactive webinar with Amazon Web Services to showcase the Company’s Venue Tracing Solution to a global audience on October 29th is indicating great success
    • THE EVENT – MAXIMUM ATTENDANCE OF 1,000 ACHIEVED
    • THE RESPONSE – OVERWHELMING DIRECT INQUIRIES SPANNING THE WORLD
    • EVENT BUILDS ON AMAZON APPOINTMENT OF LOOP INSIGHTS TO PREFERRED PARTNER NETWORK INCLUDING 90% OF FORTUNE 100
  • Webinar achieved its maximum attendance of 1,000 viewers, with more than 88% of viewers remaining engaged through to the end of the final Q&A segment
  • Presentation ended at approximately 1:15 PM EST, and by 8:00 PM EST Loop had received over 100 direct inquiries from enterprise-level attendees spanning many different industries and countries

VANCOUVER, British Columbia, Oct. 30, 2020 — Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated contact tracing to the brick and mortar space, is pleased to announce that early response from its interactive webinar with Amazon Web Services to showcase the Company’s Venue Tracing Solution to a global audience on October 29th is indicating great success.

THE EVENT – MAXIMUM ATTENDANCE OF 1,000 ACHIEVED

Amazon Web Services (AWS) Principal Solutions Architect Mike Apted and Loop Insights CEO Rob Anson co-hosted the event to provide invitees with a first hand and interactive experience of Loop’s End-To-End Venue Tracing Platform.

The webinar was an open invitation to AWS and Loop partners from around the world from industries including but not limited to:

  • Airlines
  • Venue Owners
  • Sports & Entertainment Enterprises
  • Professional Sports Teams
  • Telecom
  • Government

The webinar achieved its maximum attendance of 1,000 viewers, with more than 88% of viewers remaining engaged through to the end of the final Q&A segment.

THE RESPONSE – OVERWHELMING DIRECT INQUIRIES SPANNING THE WORLD

The presentation ended at approximately 1:15 PM EST, and by 8:00 PM EST Loop had received over 100 direct inquiries from enterprise-level attendees spanning many different industries and countries. Loop Insights anticipates many more direct inquiries to be received in the coming days.

Loop Insights CEO Rob Anson stated, “We knew going into the webinar that interest in our Contactless Platform and Solutions was very high given the high-level nature of clients we had already announced leading up to it. These attendees, many of whom represent household name entities, were looking to us for solutions that can protect people, instill confidence in their customers and get their enterprises moving once again. Nonetheless, the response to the demonstration of our Contactless Venue Tracing Platform was simply incredible and even surpassed our expectations. We are optimistic that Loop Insights is establishing an identity as a global force in the contactless space and believe the responses will lead to significant business for Loop. We can’t thank Amazon Web Services enough for their continued support and partnership.”

EVENT BUILDS ON AMAZON APPOINTMENT OF LOOP INSIGHTS TO PREFERRED PARTNER NETWORK INCLUDING 90% OF FORTUNE 100

On June 8, 2020, Loop was accepted into Amazon Web Services Partner Network (APN), the global partner program for leading technology businesses from which more than 90% of Fortune 100 companies source their solutions and services.

Some of the benefits of the APN include networking opportunities to gain access to hundreds of ongoing AWS portfolios, as well as co-development projects and continued AWS resources that support product development, marketing, and sales.

With many, if not most AWS business accounts facing significant economic challenges requiring solutions that can safely and effectively re-start normalized operations and financial recovery, Loop’s APN status in conjunction with AWS position as a trusted source of solutions is expected to create continued significant interested in Loop’s Venue Tracing Platform.

LOOP INSIGHT VENUE TRACING PLATFORM IS BUILT AND SUPPORTED BY AWS CLOUD INFRASTRUCTURE

Loop’s Venue Tracing platform is clearly gaining recognition and third-party validation, including implementations with:

  • Major Las Vegas Hospitality Chains
  • University of Houston;
  • NCAA #VegasBubble; and
  • Most recently being accepted into the TELUS IoT Marketplace as “one of the most advanced IoT business solutions in the world”

Watch the Webinar Here: www.vimeo.com/473626603

LOOP RECEIVES DTC ELIGIBILITY

Loop is also pleased to announce that it has secured The Depository Trust Company (DTC) eligibility for its shares traded in the United States under the symbol RAMCF. The Company’s common shares traded on the OTC Market in the United States, under the symbol “RAMCF” are Depository Trust Company (“DTC”) eligible, effective October 29, 2020. The DTC will facilitate electronic settlement of transfers of its common shares in the United States.

Rob Anson stated , “We are very pleased to have obtained DTC eligibility. Loop is registering its shares with DTC as a fundamental step towards establishing the Company with the American investment community. This electronic method of clearing securities expedites the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms. The DTC’s electronic settlement of our shares is critical to having an effective market.”

This press release is available on the Loop Insights Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/LoopInsights

About Loop Insights : Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop s products and services are backed by Amazon s Partner Network.

For more information, please contact: 
Loop Insights Inc.LOOP Website : www.loopinsights.ai 
Rob Anson, CEOFacebook: @ LoopInsights 
T : +1 877-754-5336 Ext. 4Twitter: @ LoopInsights 
E : [email protected]LinkedIn: @ LoopInsights 

Forward-Looking Statements/Information:

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Could #Cannabis Eliminate The High-Cost And High-Stakes Of Current #Psoriasis Medicines? SPONSOR: Innocan Pharma $INNO.ca $IN.ca $AXIM $LABS $CRDL.ca $TBP.ca

Posted by AGORACOM-JC at 6:04 PM on Thursday, October 29th, 2020

SPONSOR: Innocan Pharma Corporation (INNO:CSE) (IP4:FSE) Innocan has 3 fully operating divisions to address the market for Cannabis products.  As a Cannabis investor, why limit yourself to a Company with just one specialty, when Innocan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products. In addition, the company filed an international patent application for a novel cannabis-based psoriasis treatment. This patent application makes claim of a topical pharmaceutical composition used to treat the symptoms of itching and inflammation associated with psoriasis.

  • “The global psoriasis drugs market is forecast to reach USD 39.00 Billion by 2027.
Innocan-Blog

Could Cannabis Eliminate The High-Cost And High-Stakes Of Current Psoriasis Medicines?

  • Often triggered by stress, new studies are showing that psoriasis can be better managed by diet, oral health, and even cannabidiol.
  • The National Psoriasis Foundation shared information on a study from the Journal of Dermatological Science showcasing that, “CBD may offer therapeutic value for psoriasis by slowing the overgrowth of certain skin cells.” 
  • A 2016 study published in the journal Current Clinical Pharmacology found similar results, citing that cannabinoids may be a positive addition to treatment for psoriasis.
  • Even better, a 2018 study did a sweeping review of prior research on cannabis’ role within dermatology and found, “cannabinoids have shown some initial promise as a therapy for a variety of skin diseases.” Their only concern was a lack of research in clinical trials, due to the Schedule 1 classification of the drug.  

By: Kate-Madonna Hindes

The National Psoriasis Foundation states that upwards of 8 million people have the auto-immune skin disorder. Often accompanied by arthritis, psoriasis not only causes scaling of the skin, but complications to fingernails as well. 

Affecting everyone from children to adults, psoriasis can lead to anxiety and depression, as individuals with the skin disorder are often afraid of being ridiculed. Usually treated with Humira and Enbrel, psoriasis comes with a shocking price tag and complications that are often difficult to ignore. 

A 2014 study published in the journal Drugs in Context found that Humira had a price tag upwards of $39,000, while Enbrel’s annual cost was around $46,000. Stelara, the most expensive drug, was found to cost over $53,000. As TNF blockers, while medications like Humira help against psoriasis, they can lower the body’s ability to fight infections and cause serious side effects.

Even more interesting, a September 2019 study in London found that, “A number of medications commonly prescribed by rheumatologists may interact with cannabidiol oil” (CBD oil). The most affected medicines appear to be corticosteroids (including hydrocortisone and prednisolone) since CBD, “is a potent inhibitor of CYP3A.” Put plainly, CBD may block the effects of the other medicine.

Image Credit: Aleksandr_Kravtsov | Getty Images via The Fresh Toast

Can CBD alone help psoriasis? 

Often triggered by stress, new studies are showing that psoriasis can be better managed by diet, oral health, and even cannabidiol. The National Psoriasis Foundation shared information on a study from the Journal of Dermatological Science showcasing that, “CBD may offer therapeutic value for psoriasis by slowing the overgrowth of certain skin cells.” 

A 2016 study published in the journal Current Clinical Pharmacology found similar results, citing that cannabinoids may be a positive addition to treatment for psoriasis. Even better, a 2018 study did a sweeping review of prior research on cannabis’ role within dermatology and found, “cannabinoids have shown some initial promise as a therapy for a variety of skin diseases.” Their only concern was a lack of research in clinical trials, due to the Schedule 1 classification of the drug.  

While CBD and cannabis offer pain relief and psoriasis is often accompanied by rheumatoid arthritis, each individual must discuss the addition of any new medicine (including CBD and cannabis) with their care team. With new clinical trials for cannabinoids and psoriasis recruiting even now, promising cures may be on the horizon.

Source: https://www.greenentrepreneur.com/article/358275

Defense Market Size Anticipated To Exceed USD 10.5 Billion By 2023 – SPONSOR: KWESST Micro Systems $KWE.ca $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 5:28 PM on Thursday, October 29th, 2020

SPONSOR POST:

WHY KWESST? HERE’S SOME GREAT REASONS

1.   KWESST is a leader in defensive technologies that increase the capabilities of soldiers, including
those of NATO and its allies

2.  These technologies make a critical difference to soldier safety and effectiveness

3.  The Leadership team experience spans decades and hundreds of millions of dollars in military and homeland security contracts.

4.  KWESST develops next-generation systems for forces around the world, with a particular focus on special forces among NATO countries and their allies.

Image-1

5.  KWESST partners with globally recognized equipment manufacturers to integrate its systems into
their solutions to create high value-add products for global customers.

Image-2

KWESST Upgraded to SAMSUNG “USA Partner” Status

  • Announced the elevation of its affiliation with SAMSUNG Electronics America Inc. to “USA Partner” status
  • KWESST will be employing the SAMSUNG S20TE tactical smart phone in the production version of the Company’s Tactical Awareness and Situational Control System (TASCS) and for its Integrated Fires Module (IFM) for networked targeting on soldiers’ weapons
  • SAMSUNG S20TE device, also known as the Galaxy S20 Tactical Edition, is the latest mission-ready military smartphone built and proven by operators in special operations for rapid information capture, sharing and analysis in diverse operating environments

6.  KWESST provides small cap investors with a rare opportunity to invest in a high-growth, technology driven, global defence company with:

  • Tier-1 Customers
  • Global Customers
  • Proprietary Technologies
  • Diversified Products
  • Globally Renowned Executive Team With Massive Successful Track Records

—————–

Defense Market Size Anticipated To Exceed USD 10.5 Billion By 2023

Defense market size was valued around USD 6 billion in 2014 and is anticipated to exceed USD 10.5 billion by 2023, growing at a CAGR of over 6.1% from 2016 to 2023. The growth can be mainly attributed to increasing technological innovation and advancement. The technological improvements are expected to improvise the military power and thus resulting in making it stronger. Various nations are now concentrating on developing the protection systems for themselves as well as to trade with other militaries.

Proliferating security concerns among various nations and rising government spending in research and development activities is likely to propel the industry growth. Nations assessment of its security is mainly responsible for shaping its security system. As the country’s economy grows its security spending also increases. Nations are now retooling their fighting abilities towards more affordable and updated technology.

Countries such as China, Israel and Russia defense market see significant spending in improvising their resistance systems. As of 2015, U.S spends around 54% of its fiscal budget for military utilities and accounted for 37% of the overall industry share. It spends as much as USD 610 billion and ranks first in case of defense expenditure across the globe. Japan, China, United Kingdom, Russia, Germany, South Korea, France, Saudi Arabia and India collectively valued for USD 601 billion in 2015.

The global defense market is estimated to face two major challenges over the forecast period namely, profitability growth and cost cutting to maintain financial performance. In order to tackle these conditions several counties namely India is now focusing on defense foreign investments and technology platforms for increasing production operations in the country. As of 2015, The Ministry of Commerce and Industry (MC&I) has modified its FDI limit from 26% to 49% in order to improve country’s own security system. Moreover, declining resistance budgets accompanied by rising development costs is expected to hamper defense market growth from 2016 to 2023.

In addition, countries namely UAE, Saudi Arabia, India, South Korea, Japan, China and Russia exhibit potential growth prospects owing to threat from other countries. Defense companies are expected to witness huge growth opportunities owing to increasing investment in next generation ISR, unmanned combat land and sea vehicles, cognition & data analytics as well as improved precision strike with the assistance of non kinetic weapons. The defense market can be segmented on the basis of platform which includes airborne, naval and land based.

U.S. MDA (Missile Defense Agency) and Raytheon are jointly working on development of MOKV (Multi-Object Kill Vehicle) concept. These are specialized equipments that are likely to steer itself to the target and destroy the objects in space. In addition, India has test fired its AAD (advanced air defense) interceptor missile developed by DRDO (Defense Research and Development Organisation). It is a single-stage, anti-ballistic missile designed to suspend incoming missiles from an altitude of 30 kms. When integrated with Prithvi air defense missile, the experiment might result in two-tier ballistic missile defense system which is developed to intercept any threat from an altitude of 5000 kms.

Key industry participants in defense market share include Boeing, EADS/Airbus, United Technologies, Raytheon, Northrop Grumman and General Atomics Aeronautical Systems, ABG Shipyard Limited (ABG), Adcom Military Industries, Bharat Dynamics Limited, Brazilian Company Avionics Services, CADES Engineering Technologies Ltd, Cassidian Cyber Security, EBV Explosives Environmental Company, Direction des Constructions Navales Services (DCNS), BAE Systems Information and Electronic Systems Integration Inc. (US), EUREST Raytheon Support Services , European Advanced Technology S.A., Hispano-Suiza, HCL Aerospace & Defense and Advance Tech Control Pvt Ltd among others.

Source: https://www.gminsights.com/industry-analysis/defense-market

#Veganuary Celebrates 1 Million Participants As Plant-Based Diet Goes Mainstream – SPONSOR: PlantX Life $VEGA.ca $BYND $TSN $CAG $FMCI $VERY $MEAT

Posted by AGORACOM-JC at 4:20 PM on Thursday, October 29th, 2020

SPONSOR: PlantX Life Inc. (VEGA:CSE) – The Digital Face of The Plant – Based Community. The company is aiming to be the most trusted online destination for the plant-based community and those interested in living a plant-based lifestyle which includes the following;

  • Plant Based Meal Delivery – 20 unique 100% plant based meals for home delivery
  • 20,000 items including snacks, drinks and even chocolate
  • Plant Based …. PLANTS (It’s A BIG Business!)
  • Plant Based Pet foods
  • Plant Based Restaurant Locator
PlantX | LinkedIn

—————–

Veganuary Celebrates 1 Million Participant As Plant-Based Diet Goes Mainstream

  • Veganuary, the U.K.-based campaign encouraging people to eat vegan for the month of January, has just hit the 1 million supporter mark since its inception in 2014
  • The achievement is testament to the growing plant-based trend, especially in the wake of the coronavirus pandemic, which has sent consumers all over the world looking for healthier, more sustainable and safer alternatives to animal foods.

By Sally Ho

Veganuary, the U.K.-based campaign encouraging people to eat vegan for the month of January, has just hit the 1 million supporter mark since its inception in 2014. The achievement is testament to the growing plant-based trend, especially in the wake of the coronavirus pandemic, which has sent consumers all over the world looking for healthier, more sustainable and safer alternatives to animal foods. 

Announced on Monday (October 26), Veganuary has welcomed its one millionth participant joining the movement to try veganism for 31 days. Since the campaign first began in 2014, it has attracted the support of big names, including television presenter Jasmine Harman, actor Peter Egan and renowned wildlife presenter Chris Packham

Harman, who took part in the first-ever Veganuary six years ago, broadcasted a video message congratulating the charity on the milestone. “I feel very proud and very privileged to have been with Veganuary from the start and to be one of their ambassadors,” she said. 

In its first year, Veganuary attracted just 3,300 supporters, but it quickly rose to fame as plant-based foods have come to garner greater spotlight in recent years as consumers begin to couple the environmental footprint and health impact of their food choices. The one million total includes the record-breaking 400,000 participants that joined the movement this year, a jump from the 250,000 figure in 2019, and 170,000 in 2018.

One million official Veganuary participants in just seven years is a huge achievement, but the momentum behind the plant-based revolution will see us hit two million in no time. Matthew Glover, Co-Founder & Chair of Veganuary

The real figure is likely to be much higher than one million, given that people around the world are believed to have taken part in the event without signing the official pledge online. A significant number have also continued their plant-based diet after the month of January. According to research conducted by data insights firm Kantar, the actual number of people who have participated without officially signing up is around ten times higher. 

Commenting on the milestone, Matthew Glover, the co-founder and chair of the charity, said: “Now Veganuary is a bigger feature in the retail calendar than Christmas, reflecting the ever-increasing number of people choosing plant-based food.” 

“One million official Veganuary participants in just seven years is a huge achievement, but the momentum behind the plant-based revolution will see us hit two million in no time.”

Signatories to the pledge have come from every single country in the world apart from North Korea, Vatican City and Eswatini. In 2020, the most growth in supporters was recorded in Latin America, followed by India – two major markets where plant-based foods have experienced a surge in demand.

All over the world, consumers have been shifting towards plant-based foods more than ever before, particularly in the wake of the pandemic, which has exposed the vulnerabilities and dangers of the animal meat supply chain. With the trend firmly in the mainstream, food giants have been scrambling to tap into the market – the latest research shows that almost 40% of the biggest food manufacturers and retailers in the world now have dedicated plant-based teams

Plant-based meat makers have also celebrated a big win in Europe just last week, when EU leaders prevented a proposal that would ban plant-based alternatives from using “meaty” terms like sausages or burgers on their labels.

Source: https://www.greenqueen.com.hk/veganuary-celebrates-1-million-participant-as-plant-based-diet-goes-mainstream/